CVNA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Carvana is a good buy for a beginner long-term investor with $50,000-$100,000 to deploy, and I would favor buying it now rather than waiting. The stock has supportive momentum, strong institutional and congressional buying, solid analyst optimism, and no fresh negative news catalyst. While the technical setup is not perfect, the price is sitting near a key breakout area, and the overall evidence is still bullish enough to justify a long-term purchase.
CVNA is trading at 73.5, essentially flat versus the prior close and just above the first resistance level at 73.432. MACD histogram is positive and expanding, which supports near-term upside momentum. RSI_6 at 66.99 is elevated but not overbought, so momentum remains constructive. The main caution is that the moving averages are bearishly stacked with SMA_200 > SMA_20 > SMA_5, which means the longer-term trend is not fully confirmed yet. Still, price holding near resistance with positive MACD suggests the stock is attempting to continue its advance. The next upside levels are 76.741 and beyond that, while support sits at 68.076.
["Strong analyst support after Q1 results, with multiple firms raising price targets and maintaining Buy/Outperform ratings.", "Citizens cited strong Q1 results, 40% unit growth, revenue and EBITDA beats, and improving margins into the second half of 2026.", "Hedge funds are buying aggressively, with buying amount up 114.01% over the last quarter.", "Congressional trading has been positive, with 4 purchase transactions and 0 sales in the last 90 days.", "No negative news in the last week, removing near-term event pressure.", "Options positioning is constructive, with put-call ratios below 1."]
["The technical trend is not fully aligned because the moving averages are still bearishly stacked.", "RSI is relatively high, which reduces immediate upside room in the very short term.", "Some analyst target changes were largely mechanical due to the 5:1 stock split rather than fresh fundamental re-rating.", "The similar-pattern stock trend suggests a possible short-term pullback next day and next week before longer-term strength resumes."]
Latest quarter financials were not provided in usable detail, so I cannot fully assess the quarter-by-quarter numbers. However, the analyst commentary on the latest Q1 results indicates strong growth trends: retail unit growth around 40%, revenue and EBITDA beating expectations, and operational efficiency improving. The season referenced is Q1 2026, and the commentary points to continued margin improvement into the second half of 2026.
Analyst sentiment is strongly positive overall. Recent coverage includes Baird raising its target to $88 and keeping Outperform, Barclays cutting its target to $93 due to the stock split but keeping Overweight, BTIG raising to $97 and keeping Buy, Citizens raising to $515 with Outperform after strong Q1 results, Deutsche Bank raising to $537 and keeping Buy, Needham raising to $600 and keeping Buy, and Morgan Stanley raising to $510 with Overweight. The only softer note is Evercore ISI at In Line and Baird at Neutral, but the broader Wall Street view is clearly bullish. Pros: strong growth, improving operations, margin expansion potential, and broad analyst support. Cons: some target changes are split-adjustment driven, and a few firms remain more cautious on valuation and execution.
